Nordic Bioscience has more than 25 years of experience in biomarker development and clinical trials and has particular expertise in rheumatology and fibrosis. Nordic Bioscience offers more than 50 validated proprietary biomarkers to clients in the pharmaceutical and biotech industry and has successfully conducted multiple phase I-III trials in osteoporosis and osteoarthritis.

Nordic Bioscience liaises with our pharmaceutical and biotech clients to identify projects most suitable for clinical development, taking full advantage of our unique biomarker technology. We assist our clients in understanding a compound’s mode of action and optimal dosing. Our experience in clinical and preclinical research allows us to help provide a faster and smarter detection of signals of clinical viability of future treatment options.

The close collaboration between our biomarker research teams, manufacturing, sample measurement services teams, and clinical- and regulatory expertise helps ensure an unmatched level of support to our clients. We call it our Biomarker Powerhouse!

As a science-driven and specialized company we proudly publish more than 40 scientific papers annually in high-impact journals.

Rheumatology

Rheumatology constitutes the largest part of our research legacy at Nordic Bioscience as we have completed multiple clinical phase I-III trials in osteoporosis and osteoarthritis. Our proprietary biomarkers are used to detect early signals of efficacy and segregation of phenotypes to enable the development of truly Precision Medicine

Our expertise includes:

Additional therapeutic areas

Our in-depth knowledge of the extracellular matrix sustains us in spearheading the development of blood-based biomarkers within many therapeutic areas. We facilitate the understanding of biochemical disease-drivers and are able to aid in validating new potential targets for drug intervention.

Our expertise includes:


Publications

As a science-driven and specialized company we proudly publish more than 40 scientific papers annually in high-impact journals.

Protein Fingerprint Technology

Our unique Protein Fingerprint™ technology can identify and quantify disease-specific protein fragments that exceed the specificity of gold standard biomarkers with regards to biological relevance and scientific rationale.